Cardiovascular Disease in CKD
By:
Holly J. Kramer Department of Public Health, Parkinson School of Health Sciences and Public Health and Department of Medicine, Division of Nephrology and Hypertension, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois

Search for other papers by Holly J. Kramer in
Current site
Google Scholar
PubMed Close
and
Sankar D. Navaneethan Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas Section of Nephrology, and Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas

Search for other papers by Sankar D. Navaneethan in
Current site
Google Scholar
PubMed Close
Volume/Issue:
Volume 18: Issue 4
Published Online:
Sep 2019
Restricted access
Purchase Print On-Demand ASN Members Sign In Here
  • Collapse
  • Expand

Volume 18 (2019): Issue 4 (Sep 2019): Chronic Kidney Disease and Progression

in Nephrology Self-Assessment Program
Cover Nephrology Self-Assessment Program
Copyright:
© American Society of Nephrology 2019
Page Count:
13
Article Category:
Research Article
Print Publication Date:
01 Sep 2019
Published Online:
Sep 2019
  • 1.

    Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Nally JV Jr: Cause-specific deaths in non-dialysis-dependent CKD. J Am Soc Nephrol 26: 2512–2520, 2015 PubMed

  • 2.

    Thompson S, James M, Wiebe N, Hemmelgarn B, Manns B, Klarenbach S, et al.; Alberta Kidney Disease Network: Cause of death in patients with reduced kidney function. J Am Soc Nephrol 26: 2504–2511, 2015 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Bansal N, Katz R, Robinson-Cohen C, Odden MC, Dalrymple L, Shlipak MG, et al.: Absolute rates of heart failure, coronary heart disease, and stroke in chronic kidney disease: An analysis of 3 community-based cohort studies. JAMA Cardiol 2: 314–318, 2017 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Bansal N, Zelnick LR, Alonso A, Benjamin EJ, de Boer IH, Deo R, et al.: eGFR and albuminuria in relation to risk of incident atrial fibrillation: A meta-analysis of the Jackson heart study, the multi-ethnic study of atherosclerosis, and the cardiovascular health study. Clin J Am Soc Nephrol 12: 1386–1398, 2017 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5.

    Sandhu RK, Kurth T, Conen D, Cook NR, Ridker PM, Albert CM: Relation of renal function to risk for incident atrial fibrillation in women. Am J Cardiol 109: 538–542, 2012 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Massicotte-Azarniouch D, Kuwornu JP, Carrero JJ, Lam NN, Molnar AO, Zimmerman D, et al.: Incident atrial fibrillation and the risk of congestive heart failure, myocardial infarction, end-stage kidney disease, and mortality among patients with a decreased estimated GFR. Am J Kidney Dis 71: 191–199, 2018 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7.

    Keskar V, McArthur E, Wald R, Harel Z, Zimmerman D, Molnar AO, et al.: The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation. Kidney Int 91: 928–936, 2017 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Kumar S, de Lusignan S, McGovern A, Correa A, Hriskova M, Gatenby P, et al.: Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: A population based study from UK primary care. BMJ 360: k342, 2018 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9.

    Jun M, James MT, Ma Z, Zhang J, Tonelli M, McAlister FA, et al.; Alberta Kidney Disease Network: Warfarin initiation, atrial fibrillation, and kidney function: Comparative effectiveness and safety of warfarin in older adults with newly diagnosed atrial fibrillation. Am J Kidney Dis 69: 734–743, 2017 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10.

    Shroff GR, Stoecker R, Hart A: Non-vitamin K-dependent oral anticoagulants for nonvalvular atrial fibrillation in patients with CKD: Pragmatic considerations for the clinician. Am J Kidney Dis 72: 717–727, 2018 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11.

    Shin JI, Secora A, Alexander GC, Inker LA, Coresh J, Chang AR, et al.: Risks and benefits of direct oral anticoagulants across the spectrum of GFR among incident and prevalent patients with atrial fibrillation. Clin J Am Soc Nephrol 13: 1144–1152, 2018 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12.

    Kimachi M, Furukawa TA, Kimachi K, Goto Y, Fukuma S, Fukuhara S: Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease. Cochrane Database Syst Rev 11: CD011373, 2017 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13.

    Bowe B, Xie Y, Xian H, Balasubramanian S, Zayed MA, Al-Aly Z: High density lipoprotein cholesterol and the risk of all-cause mortality among U.S. veterans. Clin J Am Soc Nephrol 11: 1784–1793, 2016 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14.

    Navaneethan SD, Schold JD, Walther CP, Arrigain S, Jolly SE, Virani SS, et al.: High-density lipoprotein cholesterol and causes of death in chronic kidney disease. J Clin Lipidol 12: 1061–1071.e7, 2018 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15.

    Storey BC, Staplin N, Haynes R, Reith C, Emberson J, Herrington WG, et al.; SHARP Collaborative Group: Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation. Kidney Int 93: 1000–1007, 2018 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16.

    Kopel T, Kaufman JS, Hamburg N, Sampalis JS, Vita JA, Dember LM: Endothelium-dependent and -independent vascular function in advanced chronic kidney disease. Clin J Am Soc Nephrol 12: 1588–1594, 2017 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17.

    Yilmaz MI, Saglam M, Caglar K, Cakir E, Sonmez A, Ozgurtas T, et al.: The determinants of endothelial dysfunction in CKD: Oxidative stress and asymmetric dimethylarginine. Am J Kidney Dis 47: 42–50, 2006 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18.

    Jalal DI, Decker E, Perrenoud L, Nowak KL, Bispham N, Mehta T, et al.: Vascular function and uric acid-lowering in stage 3 CKD. J Am Soc Nephrol 28: 943–952, 2017 PubMed

  • 19.

    Vita JA, Keaney JF Jr, Larson MG, Keyes MJ, Massaro JM, Lipinska I, et al.: Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study. Circulation 110: 3604–3609, 2004 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20.

    Nowak KL, Chonchol M, Ikizler TA, Farmer-Bailey H, Salas N, Chaudhry R, et al.: IL-1 inhibition and vascular function in CKD. J Am Soc Nephrol 28: 971–980, 2017 PubMed

  • 21.

    Vila Cuenca M, Ferrantelli E, Meinster E, Pouw SM, Kovačević I, de Menezes RX, et al.: Vitamin D attenuates endothelial dysfunction in uremic rats and maintains human endothelial stability. J Am Heart Assoc 7: e008776, 2018 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22.

    Kumar V, Yadav AK, Lal A, Kumar V, Singhal M, Billot L, et al.: A randomized trial of vitamin D supplementation on vascular function in CKD. J Am Soc Nephrol 28: 3100–3108, 2017 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 23.

    Mishra RK, Li Y, Ricardo AC, Yang W, Keane M, Cuevas M, et al.; Chronic Renal Insufficiency Cohort Investigators: Association of N-terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC]). Am J Cardiol 111: 432–438, 2013 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24.

    Paoletti E, De Nicola L, Gabbai FB, Chiodini P, Ravera M, Pieracci L, et al.: Associations of left ventricular hypertrophy and geometry with adverse outcomes in patients with CKD and hypertension. Clin J Am Soc Nephrol 11: 271–279, 2016 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25.

    Untersteller K, Girerd N, Duarte K, Rogacev KS, Seiler-Mussler S, Fliser D, et al.: NT-proBNP and echocardiographic parameters for prediction of cardiovascular outcomes in patients with CKD stages G2-G4. Clin J Am Soc Nephrol 11: 1978–1988, 2016 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26.

    Foster MC, Coresh J, Bonventre JV, Sabbisetti VS, Waikar SS, Mifflin TE, et al.; CKD Biomarkers Consortium: Urinary biomarkers and risk of ESRD in the atherosclerosis risk in communities study. Clin J Am Soc Nephrol 10: 1956–1963, 2015 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 27.

    Jotwani V, Katz R, Ix JH, Gutiérrez OM, Bennett M, Parikh CR, et al.: Urinary biomarkers of kidney tubular damage and risk of cardiovascular disease and mortality in elders. Am J Kidney Dis 72: 205–213, 2018 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28.

    Park M, Shlipak MG, Katz R, Agarwal S, Ix JH, Hsu CY, et al.: Subclinical cardiac abnormalities and kidney function decline: The multi-ethnic study of atherosclerosis. Clin J Am Soc Nephrol 7: 1137–1144, 2012 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 29.

    Deo R, Shou H, Soliman EZ, Yang W, Arkin JM, Zhang X, et al.: Electrocardiographic measures and prediction of cardiovascular and noncardiovascular death in CKD. J Am Soc Nephrol 27: 559–569, 2016 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 30.

    Dobre M, Brateanu A, Rashidi A, Rahman M: Electrocardiogram abnormalities and cardiovascular mortality in elderly patients with CKD. Clin J Am Soc Nephrol 7: 949–956, 2012 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 31.

    Snitker S, Doerfler RM, Soliman EZ, Deo R, St Peter WL, Kramlik S, et al.: Association of QT-prolonging medication use in CKD with electrocardiographic manifestations. Clin J Am Soc Nephrol 12: 2017

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32.

    Khattak A, Mandel EI, Reynolds MR, Charytan DM: Percutaneous coronary intervention versus optimal medical therapy for stable angina in advanced CKD: A decision analysis. Am J Kidney Dis 69: 350–357, 2017 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 33.

    Al-Khatib SM, Hellkamp AS, Fonarow GC, Mark DB, Curtis LH, Hernandez AF, et al.: Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%. JAMA 311: 2209–2215, 2014 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 34.

    Bansal N, Szpiro A, Reynolds K, Smith DH, Magid DJ, Gurwitz JH, et al.: Long-term outcomes associated with implantable cardioverter defibrillator in adults with chronic kidney disease. JAMA Intern Med 178: 390–398, 2018 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35.

    McCausland FR, Pfeffer MA: Implantable cardioverter defibrillators in chronic kidney disease. Nat Rev Nephrol 14: 357–358, 2018 PubMed

  • 36.

    van der Sande NGC, Visseren FLJ, van der Graaf Y, Nathoe HM, de Borst GJ, Leiner T, et al.; SMART Study Group: Relation between kidney length and cardiovascular and renal risk in high-risk patients. Clin J Am Soc Nephrol 12: 921–928, 2017 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 37.

    Kestenbaum BR, Adeney KL, de Boer IH, Ix JH, Shlipak MG, Siscovick DS: Incidence and progression of coronary calcification in chronic kidney disease: The multi-ethnic study of atherosclerosis. Kidney Int 76: 991–998, 2009 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 38.

    Chen J, Budoff MJ, Reilly MP, Yang W, Rosas SE, Rahman M, et al.; CRIC Investigators: Coronary artery calcification and risk of cardiovascular disease and death among patients with chronic kidney disease. JAMA Cardiol 2: 635–643, 2017 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 39.

    Jovanovich A, Isakova T, Block G, Stubbs J, Smits G, Chonchol M, et al.: Deoxycholic acid, a metabolite of circulating bile acids, and coronary artery vascular calcification in CKD. Am J Kidney Dis 71: 27–34, 2018 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 40.

    Charytan DM, Skali H, Shah NR, Veeranna V, Cheezum MK, Taqueti VR, et al.: Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage. Kidney Int 93: 501–509, 2018 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 41.

    Zelnick LR, Katz R, Young BA, Correa A, Kestenbaum BR, de Boer IH, et al.: Echocardiographic measures and estimated GFR decline among African Americans: The Jackson heart study. Am J Kidney Dis 70: 199–206, 2017 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 42.

    Bansal N, Roy J, Chen HY, Deo R, Dobre M, Fischer MJ, et al.; CRIC Study Investigators: Evolution of echocardiographic measures of cardiac disease from CKD to ESRD and risk of all-cause mortality: Findings from the CRIC study. Am J Kidney Dis 72: 390–399, 2018 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 43.

    Matsushita K, Ballew SH, Coresh J, Arima H, Ärnlöv J, Cirillo M, et al.; Chronic Kidney Disease Prognosis Consortium: Measures of chronic kidney disease and risk of incident peripheral artery disease: A collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol 5: 718–728, 2017 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 44.

    Kayali F, Najjar R, Aswad F, Matta F, Stein PD: Venous thromboembolism in patients hospitalized with nephrotic syndrome. Am J Med 121: 226–230, 2008 PubMed

  • 45.

    Mahmoodi BK, Gansevoort RT, Næss IA, Lutsey PL, Brækkan SK, Veeger NJ, et al.: Association of mild to moderate chronic kidney disease with venous thromboembolism: Pooled analysis of five prospective general population cohorts. Circulation 126: 1964–1971, 2012 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 46.

    Cheung KL, Zakai NA, Folsom AR, Kurella Tamura M, Peralta CA, Judd SE, et al.: Measures of kidney disease and the risk of venous thromboembolism in the REGARDS (reasons for geographic and racial differences in stroke) study. Am J Kidney Dis 70: 182–190, 2017 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 47.

    Massicotte-Azarniouch D, Bader Eddeen A, Lazo-Langner A, Molnar AO, Lam NN, McCallum MK, et al.: Risk of venous thromboembolism in patients by albuminuria and estimated GFR. Am J Kidney Dis 70: 826–833, 2017 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 48.

    Agarwal R: Prevalence, determinants and prognosis of pulmonary hypertension among hemodialysis patients. Nephrol Dial Transplant 27: 3908–3914, 2012 PubMed

  • 49.

    Navaneethan SD, Roy J, Tao K, Brecklin CS, Chen J, Deo R, et al.; Chronic Renal Insufficiency Cohort Investigators: Prevalence, predictors, and outcomes of pulmonary hypertension in CKD. J Am Soc Nephrol 27: 877–886, 2016 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 50.

    Tang M, Batty JA, Lin C, Fan X, Chan KE, Kalim S: Pulmonary hypertension, mortality, and cardiovascular disease in CKD and ESRD patients: A systematic review and meta-analysis. Am J Kidney Dis 72: 75–83, 2018 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 51.

    Kurella Tamura M, Muntner P, Wadley V, Cushman M, Zakai NA, Bradbury BD, et al.: Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States. Am J Kidney Dis 58: 756–763, 2011 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 52.

    Weiner DE, Gaussoin SA, Nord J, Auchus AP, Chelune GJ, Chonchol M, et al.; SPRINT Study Research Group: Cognitive function and kidney disease: Baseline data from the systolic blood pressure intervention trial (SPRINT). Am J Kidney Dis 70: 357–367, 2017 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 53.

    Freedman BI, Sink KM, Hugenschmidt CE, Hughes TM, Williamson JD, Whitlow CT, et al.; AA-DHS MIND and ACCORD MIND Investigators: Associations of early kidney disease with brain magnetic resonance imaging and cognitive function in African Americans with type 2 diabetes mellitus. Am J Kidney Dis 70: 627–637, 2017 PubMed

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 19 19 1
Full Text Views 8 8 1
PDF Downloads 16 16 2